Did You Know...
...that Robert Adler has the dubious distinction of being the Father of the Couch Potato? Back in 1955 Adler was employed by what was then Zenith Radio Corp., where he was charged to invent something that would allow viewers to turn down the TV volume without leaving their chairs. After a series of flops (such as a wired contraption that people tripped over), Adler hit on the idea of using sound waves. Thus the Remote Control was born...
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20110319499 | Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease The present invention provides compositions and methods for detecting carboxymethyl-lysine (CML) and circulating receptor for advanced glycation end (RAGE) products, and methods for correlating CML and RAGE levels with age-related disease, hi particular, serum CML and/o... | 12/29/2011 |
| 20110301248 | COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human serum albumin and/or deferoxamine. He human serum albumin is present in an am... | 12/08/2011 |
| 20110300127 | DRUG-CONTAINING COMPOSITION It is an object of the present invention to provide a drug-containing composition capable of stably retaining a water-soluble compound without the loss of drug efficacy of a pharmaceutically active ingredient and thus preventing the compound from diffusing in the body, ... | 12/08/2011 |
| 20110268666 | NOVEL GASTRORETENTIVE DELIVERY SYSTEM A novel gastroretentive delivery system comprising a tablet comprising a pharmaceutical ingredient or diagnostic, which tablet comprises a gas releasing ingredient or a tandem of two gas releasing ingredients, an ingredient capable of unrestricted swelling in gastric fl... | 11/03/2011 |
| 20110238000 | POLYMER-CONJUGATED ALBUMIN HYDROGELS FOR CONTROLLED RELEASE OF THERAPEUTIC AGENTS A hydrogel system comprising polymer-conjugated albumin molecules is provided for controlled release delivery of therapeutic agents. The polymer is a functionalized synthetic polymer, preferably PEG-diacrylate. The polymer-conjugated albumin is preferably mono-PEGylated... | 09/29/2011 |
| 20110176997 | METHOD TO MAKE POROUS MATERIALS AND THEIR APPLICATIONS The present invention relates a method to make porous materials which are useful in pharmaceutical, medicine, industry, and agriculture. The most advantage of the porous materials is to provide extremely large surface area for further modification and to incorporate a b... | 07/21/2011 |
| 20110064794 | Drug Delivery System, its Preparation Process and Use A protein-phospholipid dispersion preparation in a drug delivery system is provided, in which the weight ratio of protein to phospholipid is 1:300-300:1 and the particle size is between 5 nm and 1000 nm. The preparation process of the said preparation contains the mixtu... | 03/17/2011 |
| 20110038913 | Polymeric endoprostheses with modified erosion rates and methods of manufacture An erodible prosthesis comprising alternate rates of erosion is disclosed, wherein said alternate rates of erosion can be selectively initiated. Some embodiments according to the invention may comprise an agent for initiating an alternative rate of erosion, such as, for... | 02/17/2011 |
| 20110009497 | DRUG-CONTAINING COMPOSITION It is an object of the present invention to provide a drug-containing composition which is capable of dissolving a poorly water-soluble drug, has low toxicity to the human body, and has high binding affinity with drugs. The present invention provides a composition which... | 01/13/2011 |
| 20100322993 | INJECTABLE BIOCOMPATIBLE COMPOSITION The invention relates to an injectable biocompatible composition based on a polymeric support as well as to a method for producing it, which composition which comprises at least one hydrophilic polymer, wherein the polymer is polymerizable in situ to form a gel, and whe... | 12/23/2010 |
| 20100209353 | TUMOR TARGETING PROTEIN CONJUGATE AND A METHOD FOR PREPARING THE SAME The present invention relates to a protein conjugate having excellent tumor targeting capacity and a method for preparing the same, more precisely albumin-bile acid conjugate forming 30-500 nm nano-particles and forming self-aggregates in water system and a method for p... | 08/19/2010 |
| 20100166874 | Technology for Preparation of Macromolecular Microspheres Microspheres are produced by contacting an aqueous solution of a protein or other macromolecule with an organic solvent and a counterion, and chilling the solution. The microspheres are useful for preparing pharmaceuticals of defined dimensions.... | 07/01/2010 |
| 20090304804 | Biologic devices for hemostasis A microscopic protein device and the method of manufacture and the use of such a device for hemostasis. The device, made with biologic material such as serum albumin from a human or animal source, is less than five micron in any one dimension and typically less than one... | 12/10/2009 |
| 20090258039 | Method of administering a pharmaceutical active ingredient A method for reducing the friability of soft substrates by applying an effective amount of a water soluble, polymeric dispersion to at least a portion of a treatment surface of the substrate, such that less than about 90% of the exterior surface has the dispersion appli... | 10/15/2009 |
| 20090181090 | Protein-Based Carrier System for Overcoming Resistance in Tumour Cells Nanoparticles, the particle matrix of which is based on at least one protein and has at least one active agent embedded therein and methods of producing the nanoparticles with at least one active agent embedded in the protein matrix are disclosed. The use of the nanopar... | 07/16/2009 |
| 20090130159 | WATER-DISPERSIBLE NANOPARTICLE CONTAINING MICROBICIDE It is an object of the present invention to provide a nanoparticle containing a microbicide and a biodegradable polymer, which is safe and excellent in terms of dispersion stability and has high transparency and good absorbability due to its small particle size. The pre... | 05/21/2009 |
| 20090104291 | WATER-DISPERSIBLE NANOPARTICLE WHICH CONTAINS BLOOD CIRCULATION PROMOTER It is an object of the present invention to provide a nanoparticle which comprises a blood circulation promoter and a biodegradable polymer, which is safe and excellent in terms of dispersion stability and has high transparency and good absorbability due to its small pa... | 04/23/2009 |
| 20090041848 | SKIN ANTI-AGING AGENT FOR EXTERNAL USE It is an object of the present invention to provide a skin anti-aging agent for external use which comprises highly safe protein nanoparticles having high transparency due to the small particle size and high permeability into skin. The present invention provides a skin ... | 02/12/2009 |
| 20080286364 | EXTERNAL DERMATOLOGIC PREPARATION An object of the present invention is to provide an external dermatologic preparation which comprises nanoparticles consisting of proteins that can exhibit desirable effects via regulation of particle diameters. The present invention provides an external dermatologic pr... | 11/20/2008 |
| 20080262444 | Percutaneously Absorbable Preparation, Percutaneously Absorbable Preparation Holding Sheet, and Percutaneously Absorbable Preparation Holding Equipment Self-dissolving needle-like or filamentous shape percutaneously absorbable preparations, by which inherently poorly absorbable drugs into the body through the skin is efficiently administered. The preparations are made of at least one material selected from the group co... | 10/23/2008 |
| 20080193481 | Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines The present invention provides immunogenic oligosaccharide compositions and methods of making and using them. In particular, the compositions comprise native O-linked and S-linked oligosaccharides coupled to a protein carrier via a linker, wherein the resultant conjugat... | 08/14/2008 |
| 20080160063 | Compositions and Methods for Producing Vascular Occlusion Using a Solid-Phase Platelet Binding Agent The present invention relates generally to methods and compositions for targeting and delivering solid-phase platelet-dependent vascular occlusion agents. In particular, particles or coils or stents coated with platelet binding agents are directed to target vasculature,... | 07/03/2008 |
| 20080108708 | Method for Producing Albumin Conjugates Containing Gyrase Inhibitors The present invention concerns gyrase inhibitor-protein conjugates and in particular gyrase inhibitor-albumin conjugates, pharmaceutical preparations comprising gyrase inhibitor-protein conjugates in particular for the treatment and/or prophylaxis of inflammatory proces... | 05/08/2008 |
| 20080096977 | BIOCOMPATIBLE PHASE INVERTABLE PROTEINACEOUS COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME Biocompatible phase invertable proteinaceous compositions and methods for making and using the same are provided. The subject phase invertable compositions are prepared by combining a proteinaceous substrate and a cross-linker. The proteinaceous substrate includes one o... | 04/24/2008 |
| 20070232536 | Pharmaceutical compositions containing plasma protein The invention is related to water-soluble products and pharmaceutical formulations in solid or liquid form mainly for parenteral use. They consist of or comprise a therapeutically active substance (having low aqueous solubility and a substantial binding affinity to plas... | 10/04/2007 |
| 20070129448 | COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human serun albumin and/or deferoxamine. The human serum albumin is present in an a... | 06/07/2007 |
| 20060275294 | METHOD OF PREVENTION AND TREATMENT OF AGING, AGE-RELATED DISORDERS AND/OR AGE-RELATED MANIFESTATIONS INCLUDING ATHEROSCLEROSIS, PERIPHERAL VASCULAR DISEASE, CORONARY ARTERY DISEASE, OSTEOPOROSIS, ARTHRITIS, TYPE 2 DIABETES, DEMENTIA, ALZHEIMERS DISEASE AND CANCER This invention relates to a method for prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, type 2 diabetes, dementia and some forms of a... | 12/07/2006 |
| 20050059574 | Compositions of stable T3 and methodes of use thereof This invention provides a stable composition containing T3, serum albumin and water, wherein the T3 has a half-life of at least five days, particularly at neutral pH. This invention further provides a method for emergency treatment of a patient wit... | 03/17/2005 |
